SG Americas Securities’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

SG Americas Securities’s Portfolio SCR Stock Details SCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-134,813	Closed	-$1.29M	–	3032
2013 Q4	$1.29M	Buy	+134,813	New	+$1.28M	0.01%	1097

SG Americas Securities's SCR Position: Q1 2014 in Review

SG Americas Securities sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 134,813 shares — an estimated $1.29M sold.

SG Americas Securities first reported a position in SCR in Q4 2013 and held it in 1 quarter. The position peaked at $1.29M in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

SG Americas Securities reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
SG Americas Securities sold 134,813 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $1.29M.
SG Americas Securities first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q4 2013 and held it in 1 quarter.
SG Americas Securities's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $1.29M in Q4 2013.
0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on SG Americas Securities's 13F filing for Q1 2014, filed 14 May 2014.